Search

Your search keyword '"Lung cancer, Non-small cell -- Research -- Care and treatment"' showing total 3 results
Start Over Descriptor "Lung cancer, Non-small cell -- Research -- Care and treatment" Publisher athena information solutions pvt. ltd.
3 results on '"Lung cancer, Non-small cell -- Research -- Care and treatment"'

1. Shanghai Henlius Biotech: Cancer Cell Published the Results of ASTRUM-004 - HANSIZHUANG Combined with Chemotherapy for the First-line Treatment of sqNSCLC

Subjects
Metastasis -- Care and treatment -- Research, Biotechnology -- Research, Lung cancer, Non-small cell -- Research -- Care and treatment, Cancer -- Care and treatment, Business, Business, international
Abstract

ASTRUM-004, a phase 3 clinical study of HANSIZHUANG plus chemotherapy for sqNSCLC, was published in Cancer Cell. The study showed that serplulimab in combination with chemotherapy significantly improved survival in [...]

Published
2024

2. US FDA accepts for review Merck's sBLA for Keytruda as adjuvant therapy for stage IB -IIIA NSCLC following complete surgical resection

Subjects
United States. Food and Drug Administration, Merck Research Laboratories, Cancer -- Care and treatment, Lung cancer, Non-small cell -- Research -- Care and treatment, Pharmaceutical industry -- Research, Surgery -- Research, Pharmaceuticals and cosmetics industries, Keytruda (Medication) -- Research
Abstract

Merck, known as MSD outside the United States and Canada, announced the US Food and Drug Administration (FDA) has accepted for review a new supplemental Biologics License Application (sBLA) seeking [...]

Published
2022

3. Alphamab Oncology Announces First Patient Dosed in the Pivotal Clinical Study of KN046 for the Treatment of PD-(L)1 Refractory Advanced NSCLC

Subjects
Medical research, Medicine, Experimental, Biological products -- Research -- Planning, Viral antibodies -- Research, Clinical trials -- Research, Lung cancer, Non-small cell -- Research -- Care and treatment, Antibodies -- Research, Company business planning, Business, Business, international
Abstract

Suzhou, Oct. 29 -- Alphamab Oncology issued the following news release: Alphamab Oncology (stock code: 9966.HK) announced, a pivotal clinical study of PD-L1/CTLA-4 bispecific antibody KN046 in China (ENREACH-LUNG-02) recently [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results